In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

SmithKline makes $1.45mm equity investment in Epitope

Executive Summary

SmithKline Beecham paid $1.45mm for 200,000 common shares of Epitope (HIV diagnostics and bioagricultural products) at $7.25 per share (the closing price on July 25).
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register